Trial intelligence / Profile preview

Leech therapy and dry cupping versus LD contraceptive pills for menstrual complaints in women with polycystic ovary syndrome

IRCT20200623047903N1Phase 3Completed

Sponsor
Gonabad University of Medical Sciences
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of ethinylestradiol + levonorgestrel in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: Duration of the menstrual cycle, Menstrual bleeding volume and 1 more. Started Jul 2020; status: completed.

02

Drugs

ethinylestradiol + levonorgestrel
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT20200623047903N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200623047903N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call